![CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610819301011-fx1.jpg)
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect
![Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy](https://www.frontiersin.org/files/Articles/750478/fimmu-12-750478-HTML/image_m/fimmu-12-750478-g001.jpg)
Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
![CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-57293-y/MediaObjects/41598_2019_57293_Fig7_HTML.png)
CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports
![IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells](https://pub.mdpi-res.com/ijms/ijms-22-11302/article_deploy/html/images/ijms-22-11302-g001.png?1634780568)
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
![CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram](https://www.researchgate.net/publication/269188710/figure/fig3/AS:667620344885269@1536184502452/CD40L-and-its-receptors-the-binding-of-CD40L-to-CD40-aIIbb3-a5b1-or-Mac-1-aMb2.png)
CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram
![CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00734-4/MediaObjects/41423_2021_734_Fig1_HTML.png)